Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0002007191-25-000071
Filing Date
2025-10-14
Accepted
2025-10-14 08:36:04
Documents
7
Period of Report
2025-10-14

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS q3results6k.htm 6-K 11044
2 EX-99.1 prq3.htm EX-99.1 450
3 prq31.jpg GRAPHIC 343424
4 prq32.jpg GRAPHIC 340682
5 prq33.jpg GRAPHIC 307688
6 prq34.jpg GRAPHIC 380522
7 prq35.jpg GRAPHIC 311696
  Complete submission text file 0002007191-25-000071.txt   2331919
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42128 | Film No.: 251389913
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)